STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platforms, has announced its participation in two upcoming investor conferences in September 2025.

The company will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 8th at 1:50 PM ET. Additionally, management will present at the Q3 Investor Summit Group Virtual Conference on September 16th at 1:00 PM ET, with one-on-one meetings scheduled for September 17th.

Webcasts of both presentations will be accessible through the Investors section of Nautilus's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-0.50% News Effect

On the day this news was published, NAUT declined 0.50%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences.

  • Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY
    Management is scheduled to participate in a fireside chat on Monday, September 8h at 10:50 a.m. Pacific Time / 1:50 p.m. Eastern Time.
  • Q3 Investor Summit Group Virtual Conference
    Management is scheduled to present on Tuesday, September 16th at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time and will host 1x1 meetings on Wednesday, September 17th.

Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio


FAQ

When is Nautilus Biotechnology (NAUT) presenting at the Morgan Stanley Healthcare Conference 2025?

Nautilus will participate in a fireside chat at the Morgan Stanley conference on September 8th, 2025 at 1:50 PM Eastern Time in New York.

What conferences will Nautilus Biotechnology (NAUT) attend in September 2025?

Nautilus will attend two conferences: the Morgan Stanley 23rd Annual Global Healthcare Conference and the Q3 Investor Summit Group Virtual Conference.

How can investors access Nautilus Biotechnology's (NAUT) conference presentations?

Investors can access live and archived webcasts of the presentations through the Investors section of Nautilus's website at www.nautilus.bio.

When will Nautilus (NAUT) host one-on-one meetings at the Q3 Investor Summit?

Nautilus will host one-on-one meetings during the Q3 Investor Summit on Wednesday, September 17th, 2025.
Nautilus Biotechnology Inc

NASDAQ:NAUT

NAUT Rankings

NAUT Latest News

NAUT Latest SEC Filings

NAUT Stock Data

250.08M
71.18M
33.5%
46.34%
0.18%
Biotechnology
Laboratory Analytical Instruments
Link
United States
SEATTLE